Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Blood|November 5, 2010
Development of a recombinant antithrombin variant as a potent antidote to fondaparinux and other heparin derivativesElsa P Bianchini, Judicael Fazavana, Veronique Picard, et al.
The Journal of Biological Chemistry|October 30, 2003
The elusive role of the potential factor X cation-binding exosite-1 in substrate and inhibitor interactionsElsa P Bianchini, Robert N Pike, Bernard F Le Bonniec
Frontiers in Cardiovascular Medicine|January 25, 2021
Serpins in Hemostasis as Therapeutic Targets for Bleeding or Thrombotic DisordersElsa P Bianchini, Claire Auditeau, Mahita Razanakolona, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2005
Ratcheting of the substrate from the zymogen to proteinase conformations directs the sequential cleavage of prothrombin by prothrombinaseElsa P Bianchini, Steven J Orcutt, Peter Panizzi, et al.
Thrombosis and Haemostasis|July 15, 2016
Inactivated antithrombins as fondaparinux antidotes: a promising alternative to haemostatic agents as assessed in vitro in a thrombin-generation assayYasmine Bourti, Judicael Fazavana, Marine Armand, et al.
The Journal of Biological Chemistry|October 7, 2005
Thrombin-activable factor X re-establishes an intrinsic amplification in tenase-deficient plasmasVirginie B Louvain-Quintard, Elsa P Bianchini, Claire Calmel-Tareau, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 20, 2014
Auto-associative heparin nanoassemblies: a biomimetic platform against the heparan sulfate-dependent viruses HSV-1, HSV-2, HPV-16 and RSVDavid Lembo, Manuela Donalisio, Claire Laine, et al.
The Journal of Biological Chemistry|April 2, 2002
Mapping of the catalytic groove preferences of factor Xa reveals an inadequate selectivity for its macromolecule substratesElsa P Bianchini, Virginie B Louvain, Pierre-Emmanuel Marque, et al.
Research and Practice in Thrombosis and Haemostasis|June 17, 2024
A small-molecule hemostatic agent for the reversal of direct oral anticoagulant-induced bleedingMaximilien Desvages, Delphine Borgel, Frédéric Adam, et al.
British Journal of Haematology|January 25, 2018
Inactivated antithombin as anticoagulant reversal in a rat model of cardiopulmonary bypass: a potent and potentially safer alternative to protamineElsa P Bianchini, Alexandre Sebestyen, Toufik Abache, et al.
Pageof 2